z-logo
open-access-imgOpen Access
EFFECT OF WARM ISCHEMIA TIME AND HLA (A AND B) MATCHING ON RENAL CADAVERIC GRAFT SURVIVAL AND REJECTION EPISODES
Author(s) -
Andr Es,
J. Hermans,
J.H. van Bockel,
G. G. Persijn,
J. P. van Hooff,
J. De Graeff
Publication year - 1983
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-198309000-00006
Subject(s) - ischemia , medicine , cadaveric spasm , kidney , kidney transplantation , transplantation , warm ischemia , cold ischemia , survival analysis , renal ischemia , surgery , urology , reperfusion injury
In a retrospective single-center study the influence of warm ischemia time and simultaneous influence of HLA (A and B) matching on one-year renal graft survival was analyzed in 170 adult recipients of primary cadaveric renal grafts. One-year survival of grafts with warm ischemia times longer than 50 min was only 40% (n = 10). When warm ischemia time was shorter than 50 min, a 1-min increase of warm ischemia time correlated with 1% decrease in one-year graft survival as a result of rejection. This detrimental effect of warm ischemia time on graft survival was not yet significant one month after transplantation, but became more evident as follow-up time was lengthened. Warm ischemia time also correlated with the number of reversible rejection episodes in patients with a graft functioning for longer than one year (P less than 0.04). The beneficial influence of HLA (A and B) matching on one-year graft survival was significant (P less than 0.05 log linear test). This influence was even more evident with longer warm ischemia times. It is concluded that warm ischemia has a detrimental influence on graft survival that is mediated by rejection, and it is suggested that this might be due in part to altered presentation or expression of HLA-antigens of ischemically damaged kidney tissues.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here